Chronic effects of centrally administered adiponectin on appetite, metabolism and blood pressure regulation in normotensive and hypertensive rats

Acute studies suggest that adiponectin may reduce sympathetic activity and blood pressure (BP) via actions on the central nervous system (CNS). However, the chronic effects of adiponectin on energy expenditure and cardiovascular function are still poorly understood. We tested if chronic intracerebroventricular (ICV) infusion of adiponectin (1 or 7 mu g/day) in Sprague-Dawley rats fed a high fat diet (HFD) for 8 weeks and at the high dose (7 mu g/day) in spontaneously hypertensive rats (SHRs), a hypertensive model associated with sympathetic overactivity, evoked chronic reductions in BP and heart rate (HR). We also determined if chronic ICV adiponectin infusion alters appetite, whole body oxygen consumption (VO2), and insulin and leptin levels. Neither dose of adiponectin infused for 7 days significantly altered BP or HR in the HFD group (115 +/- 2 to 112 +/- 2 mmHg and 384 +/- 6 to 379 +/- 6 bpm at 1 mu g/day; 109 +/- 3 to 111 +/- 3 mmHg and 366 +/- 5 and 367 +/- 5 bpm at 7 mu g/day). The higher dose slightly reduced food intake (14 +/- 1 to 11 +/- 1 g/day), whereas VO2, insulin and leptin levels were not affected by the treatment. In SHRs, ICV adiponectin infusion reduced appetite (22 +/- 2 to 12 +/- 2 g/day) and insulin levels (similar to 55%), but did not alter BP (162 +/- 4 to 164 +/- 3 mmHg) or HR (312 +/- 5 to 322 +/- 8 bpm). These results suggest that adiponectin, acting via its direct actions on the CNS, has a small effect to reduce appetite and insulin levels, but it has no long-term action to reduce BP or HR, or to alter whole body metabolic rate. (c) 2012 Elsevier Inc. All rights reserved.